:

Erica C Koch Hein1,2, Francisco Villanueva3, Maysa Vilbert4

  • 1Department of Hematology and Oncology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.

Frontiers in oncology
|September 25, 2025
PubMed
概括

这项研究揭示了智利黑色素瘤患者的显著生存差异,受临床因素和医疗保健准入的影响. 早期检测,分子测试和全身疗法对于改善这种不断上升的全球癌症的结果至关重要.